Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders

Keyphrases

• Schizophrenia 100%
• Hippocampal Formation 100%
• Psychotic Disorders 100%
• Cerebral Blood Volume 100%
• Differential Targeting 100%
• Antipsychotics 60%
• Functional Magnetic Resonance Imaging 40%
• Patients with Schizophrenia 40%
• Magnetic Resonance Imaging 40%
• Psychosis 40%
• Prodromal 40%
• Rodents 20%
• Imaging Studies 20%
• High-resolution 20%
• Symptom Severity 20%
• Brain Regions 20%
• Medication Use 20%
• Healthy Controls 20%
• Dorsolateral Prefrontal Cortex (DLPFC) 20%
• Parahippocampal Region 20%
• Clinical Symptoms 20%
• Schizophrenia Symptoms 20%
• Orbitofrontal Cortex 20%
• Confounding 20%
• Vehicle Control 20%
• Related Disorders 20%
• Control Results 20%
• Volume Increase 20%
• Hospital Clinic 20%
• Clinical Progression 20%
• Longitudinal Analysis 20%
• Between-group Analysis 20%
• Correspondence Analysis 20%
• Brain Sites 20%
• Human Data 20%
• Clinical Rating Scale 20%
• Volume Decrease 20%
• Illness Progression 20%
• Prospective Cohort Design 20%
• Prodromal State 20%
• Agent-based Control 20%

Neuroscience

• Dementia Praecox 100%
• Hippocampal Formation 100%
• Psychosis 100%
• Typical Antipsychotic 50%
• Functional Magnetic Resonance Imaging 33%
• Magnetic Resonance Imaging 33%
• Dorsolateral Prefrontal Cortex 16%
• Orbitofrontal Cortex 16%
• Histopathology 16%